CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer

PURPOSE: CATCH (Comprehensive Assessment of clinical feaTures and biomarkers to identify patients with advanced or metastatic breast Cancer for marker driven trials in Humans) is a prospective precision oncology program that uses genomics and transcriptomics to guide therapeutic decisions in the cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Hlevnjak, Mario, Schulze, Markus, Elgaafary, Shaymaa, Fremd, Carlo, Michel, Laura, Beck, Katja, Pfütze, Katrin, Richter, Daniela, Wolf, Stephan, Horak, Peter, Kreutzfeldt, Simon, Pixberg, Constantin, Hutter, Barbara, Ishaque, Naveed, Hirsch, Steffen, Gieldon, Laura, Stenzinger, Albrecht, Springfeld, Christoph, Smetanay, Katharina, Seitz, Julia, Mavratzas, Athanasios, Brors, Benedikt, Kirsten, Romy, Schuetz, Florian, Fröhling, Stefan, Sinn, Hans-Peter, Jäger, Dirk, Thewes, Verena, Zapatka, Marc, Lichter, Peter, Schneeweiss, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140780/
https://www.ncbi.nlm.nih.gov/pubmed/34036222
http://dx.doi.org/10.1200/PO.20.00248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140780/
https://www.ncbi.nlm.nih.gov/pubmed/34036222
http://dx.doi.org/10.1200/PO.20.00248

Ejemplares similares